Predictors of Ibandronate Efficacy for the Management of Osteoporosis: A Meta-Regression Analysis.

about

Predictors of Ibandronate Efficacy for the Management of Osteoporosis: A Meta-Regression Analysis.

Item

http://www.wikidata.org/entity/Q35940958

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Predictors of Ibandronate Effi ...... s: A Meta-Regression Analysis.

@ast

Predictors of Ibandronate Effi ...... s: A Meta-Regression Analysis.

@en

type

Item

label

Predictors of Ibandronate Effi ...... s: A Meta-Regression Analysis.

@ast

Predictors of Ibandronate Effi ...... s: A Meta-Regression Analysis.

@en

prefLabel

Predictors of Ibandronate Effi ...... s: A Meta-Regression Analysis.

@ast

Predictors of Ibandronate Effi ...... s: A Meta-Regression Analysis.

@en

P1476

Predictors of Ibandronate Effi ...... s: A Meta-Regression Analysis.

@en

P2093

Hejun Hu

http://www.w3.org/2001/XMLSchema#string

Kedi Huang

http://www.w3.org/2001/XMLSchema#string

Ming Zhou

http://www.w3.org/2001/XMLSchema#string

Xiaoping Liu

http://www.w3.org/2001/XMLSchema#string

Xiaosheng Xu

http://www.w3.org/2001/XMLSchema#string

Yong Li

http://www.w3.org/2001/XMLSchema#string

Zeren Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men

C-terminal cross-linking telopeptide as a serologic marker for bisphosphonate-related osteonecrosis of the jaw: review of 2 cases

Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA.

Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension.

Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.

Monthly ibandronate for the prevention of bone loss in patients after liver transplantation.

Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.

The worldwide problem of osteoporosis: insights afforded by epidemiology.

Increased bone mineral density with monthly intravenous ibandronate contributes to fracture risk reduction in patients with primary osteoporosis: three-year analysis of the MOVER study.

Role of zoledronic acid in the prevention and treatment of osteoporosis.

P304

e0150203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1371/JOURNAL.PONE.0150203

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

296625783

http://www.w3.org/2001/XMLSchema#string

P698

26930292

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

P932

4773099

http://www.w3.org/2001/XMLSchema#string